Glenmark Mometasone Furoate Cream recalled over manufacturing violations
- Recall date
- November 20, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Glenmark Pharmaceuticals Inc., USA recalls Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manuf…
- Recall number
- D-0336-2018
- FDA classification
- Class II
- Brand / firm
- Glenmark Pharmaceuticals Inc., USA
- Sold / distributed
- Product was distributed throughout the United States.
Why it was recalled
CGMP Deviations: Market complaints related to "gritty texture".
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Glenmark Mometasone Furoate Cream, USP, 0.1%, 45 g Rx Only Manufactured by: Glenmark Pharmaceuticals Ltd. Village Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 NDC 68462019255 UPC 3684620192559
Get recall alerts
Free email alert whenever Glenmark Pharmaceuticals Inc., USA has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Glenmark Pharmaceuticals Inc., USA